An Open Label Multicentre Study to Determine the Dose Distribution of Paliperidone ER in Patients With Schizophrenia.
Phase of Trial: Phase III
Latest Information Update: 04 Dec 2012
At a glance
- Drugs Paliperidone (Primary)
- Indications Schizophrenia
- Focus Registrational; Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 06 Oct 2009 Actual patient number changed from 62 to 64 as reported by ClinicalTrials.gov.
- 25 Aug 2009 Actual patient number (62) added as reported by ClinicalTrials.gov.